Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ERF

Enerplus (ERF)

Enerplus Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:ERF
DateTimeSourceHeadlineSymbolCompany
04/12/20236:49AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:ERFEnerplus Corporation
04/12/20235:00AMPR Newswire (Canada)Enerplus to Report First Quarter 2023 Results May 4NYSE:ERFEnerplus Corporation
04/11/20231:37AMBusiness WireEurofins: Purchases of own shares from April, 03rd to April, 06th 2023NYSE:ERFEnerplus Corporation
04/04/20239:00AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:ERFEnerplus Corporation
04/04/20237:34AMBusiness WireEurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2023NYSE:ERFEnerplus Corporation
04/03/202310:45AMBusiness WireEurofins: Purchases of Own Shares From March, 27th to March, 31th 2023NYSE:ERFEnerplus Corporation
03/27/202310:45AMBusiness WireEurofins: Purchases of Own Shares From March, 20th to March, 24th 2023NYSE:ERFEnerplus Corporation
03/27/202312:15AMBusiness WireEUROFINS SCIENTIFIC SE : AVIS DE CONVOCATION DES ACTIONNAIRES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE DE LA SOCIETENYSE:ERFEnerplus Corporation
03/27/202312:15AMBusiness WireEurofins Scientific SE: Convening Notice of the Shareholders to the Annual Ordinary General Meeting of the Company Valid as an Information Notice for the BondholdersNYSE:ERFEnerplus Corporation
03/20/202311:45AMBusiness WireEurofins: Purchases of Own Shares From March, 13th to March, 17th 2023NYSE:ERFEnerplus Corporation
03/13/202311:45AMBusiness WireEurofins: Purchases of Own Shares from October, 06th to March, 10th 2023NYSE:ERFEnerplus Corporation
03/06/202310:45AMBusiness WirePurchases of Own Shares from October, 01st to March, 3rd 2023NYSE:ERFEnerplus Corporation
03/02/202311:44AMBusiness WireEurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2023NYSE:ERFEnerplus Corporation
03/01/20234:25PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:ERFEnerplus Corporation
03/01/20234:00PMPR Newswire (Canada)Enerplus to Present at the 51st Annual Scotia Howard Weil Energy Conference - March 7NYSE:ERFEnerplus Corporation
03/01/202312:15AMBusiness WireAfter a Very Strong 2021, Eurofins Fully Compensates for the Decline in COVID-19 Testing in 2022 and Accelerates the Build-Out of its World-Class NetworkNYSE:ERFEnerplus Corporation
02/24/20235:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:ERFEnerplus Corporation
02/24/20235:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:ERFEnerplus Corporation
02/23/20234:20PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:ERFEnerplus Corporation
02/23/20234:00PMPR Newswire (Canada)Enerplus Announces 2022 Year End Reserves ResultsNYSE:ERFEnerplus Corporation
02/23/20234:00PMPR Newswire (Canada)Enerplus Announces Fourth Quarter and Full Year 2022 Financial and Operating Results; 2023 Guidance; Updates Five-Year Outlook Through 2027NYSE:ERFEnerplus Corporation
02/23/20234:00PMPR Newswire (Canada)Enerplus Announces Quarterly Cash Dividend for March 2023NYSE:ERFEnerplus Corporation
02/20/20238:00AMBusiness WireEurofins Companies Launch SARS-CoV-2 Variant XBB.1.5 Droplet Digital PCR Assay (ddPCR) for Wastewater SurveillanceNYSE:ERFEnerplus Corporation
02/16/20236:41AMBusiness WireEurofins Viracor lance un test révolutionnaire permettant d'évaluer l'expansion et la persistance des cellules CAR-T dans le cadre des traitements administrés aux patients atteints de cancerNYSE:ERFEnerplus Corporation
02/16/202312:15AMBusiness WireEurofins Viracor Launches Ground-Breaking Test for Assessing Expansion and Persistence of CAR-T Therapy in Cancer PatientsNYSE:ERFEnerplus Corporation
02/16/202312:15AMBusiness WireEurofins Viracor Launches Ground-Breaking Test for Assessing Expansion and Persistence of CAR-T Therapy in Cancer PatientsNYSE:ERFEnerplus Corporation
02/06/202310:05AMBusiness WireEurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 January 2023NYSE:ERFEnerplus Corporation
02/01/202312:53PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:ERFEnerplus Corporation
01/18/20237:47AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:ERFEnerplus Corporation
01/18/20235:00AMPR Newswire (Canada)Enerplus to Report Fourth Quarter and Full-Year 2022 Results & Reserves February 23NYSE:ERFEnerplus Corporation
 Showing the most relevant articles for your search:NYSE:ERF